Hetero Biopharma participated in 16th Joint AFRAN/APNA Annual scientific conference at Mombasa Kenya
Hetero Biopharma, biologics arm of Hetero, associated with The Kenya Renal Association in organizing “16th Joint AFRAN (African Association of Nephrology) / APNA (African Paediatric Nephrology Association) annual scientific conference hosted at Mombasa, Kenya from 25 to 28 September.
This conference has united more than 300 health care professionals, dialysis nurses, technicians, clinicians across specialities of Nephrology, General Medicine. Around 25 speakers from Kenya, Uganda, Tanzania, Rwanda, Burundi has presented views on the theme “Improving Kidney Care in Africa”.
An exclusive booth space with Derise branding paved a path for 185+ delegates for discussion on role of biosimilars in treating anaemia due to CKD. As an add on we could bag an opportunity to unveil a poster conceptualised on ease of conversion of Epoetin to Darbepoetin, by Dr.Ahmed Twahir, Chairman, Kenya Renal Association.
An exclusive scientific lecture on Darbepoetin by our KOL Col(Dr). Obilo Milton Nephrologists, from Defence Forces Medical Hospital Nairobi Kenya, aimed to highlight the role of Darbepoetin in treating anaemia in CKD served the purpose.
Indeed it was the great efforts by the HBL Africa team headed by Mr.Krishna Kishore Regional Head- Africa Biosimilars Business and team, marketing support led by Dr.A V Jayapala Reddy AVP & Global Head- Biologics Business, Mr. Ramesh Reddy Manager – Marketing, Sharath Devalapelly – Asst Manager- Marketing, created a positive scope for biosimilars in Nephrology space in Africa.
Under KBB (Knowledge Beyond Borders), a global knowledge sharing initiative of Hetero Biopharma we firmly believe that participating in the regional conferences, helps us in raising awareness on biosimilars and unique products like Derise(Darbepoetin) to the medical fraternities in emerging markets.